| Recent advances in nanoparticle-based cancer drug and gene delivery N Amreddy, A Babu, R Muralidharan, J Panneerselvam, A Srivastava, ... Advances in cancer research 137, 115-170, 2018 | 233 | 2018 |
| Nanosomes carrying doxorubicin exhibit potent anticancer activity against human lung cancer cells A Srivastava, N Amreddy, A Babu, J Panneerselvam, M Mehta, ... Scientific reports 6 (1), 38541, 2016 | 167 | 2016 |
| Folate receptor-targeted nanoparticle delivery of HuR-RNAi suppresses lung cancer cell proliferation and migration R Muralidharan, A Babu, N Amreddy, K Basalingappa, M Mehta, A Chen, ... Journal of nanobiotechnology 14, 1-17, 2016 | 89 | 2016 |
| Exosomes as drug delivery vehicle and contributor of resistance to anticancer drugs M Chinnappan, A Srivastava, N Amreddy, M Razaq, V Pareek, R Ahmed, ... Cancer letters 486, 18-28, 2020 | 83 | 2020 |
| Tumor-targeted and pH-controlled delivery of doxorubicin using gold nanorods for lung cancer therapy N Amreddy, R Muralidharan, A Babu, M Mehta, EV Johnson, YD Zhao, ... International journal of nanomedicine, 6773-6788, 2015 | 82 | 2015 |
| HuR-targeted small molecule inhibitor exhibits cytotoxicity towards human lung cancer cells R Muralidharan, M Mehta, R Ahmed, S Roy, L Xu, J Aubé, A Chen, ... Scientific reports 7 (1), 9694, 2017 | 78 | 2017 |
| Nanoparticles for siRNA-based gene silencing in tumor therapy A Babu, R Muralidharan, N Amreddy, M Mehta, A Munshi, R Ramesh IEEE transactions on nanobioscience 15 (8), 849-863, 2016 | 76 | 2016 |
| HuR silencing elicits oxidative stress and DNA damage and sensitizes human triple-negative breast cancer cells to radiotherapy M Mehta, K Basalingappa, JN Griffith, D Andrade, A Babu, N Amreddy, ... Oncotarget 7 (40), 64820, 2016 | 72 | 2016 |
| Human herpesvirus 8 load and progression of AIDS-related Kaposi sarcoma lesions MM Nsubuga, RJ Biggar, S Combs, V Marshall, G Mbisa, F Kambugu, ... Cancer letters 263 (2), 182-188, 2008 | 62 | 2008 |
| Progress in extracellular vesicle biology and their application in cancer medicine A Srivastava, N Amreddy, V Pareek, M Chinnappan, R Ahmed, M Mehta, ... Wiley Interdisciplinary Reviews: Nanomedicine and Nanobiotechnology 12 (4 …, 2020 | 58 | 2020 |
| YAP1 inhibition radiosensitizes triple negative breast cancer cells by targeting the DNA damage response and cell survival pathways D Andrade, M Mehta, J Griffith, J Panneerselvam, A Srivastava, TD Kim, ... Oncotarget 8 (58), 98495, 2017 | 46 | 2017 |
| Inducing Mild Traumatic Brain Injury in C. elegans via Cavitation-Free Surface Acoustic Wave-Driven Ultrasonic Irradiation M Miansari, MD Mehta, JM Schilling, Y Kurashina, HH Patel, J Friend Scientific reports 9 (1), 12775, 2019 | 27 | 2019 |
| HuR reduces radiation-induced DNA damage by enhancing expression of ARID1A D Andrade, M Mehta, J Griffith, S Oh, J Corbin, A Babu, S De, A Chen, ... Cancers 11 (12), 2014, 2019 | 26 | 2019 |
| RNA binding proteins (RBPs) and their role in DNA damage and radiation response in cancer M Mehta, R Raguraman, R Ramesh, A Munshi Advanced drug delivery reviews 191, 114569, 2022 | 25 | 2022 |
| Regorafenib sensitizes human breast cancer cells to radiation by inhibiting multiple kinases and inducing DNA damage M Mehta, J Griffith, J Panneerselvam, A Babu, J Mani, T Herman, ... International journal of radiation biology 97 (8), 1109-1120, 2021 | 25 | 2021 |
| Silencing BMI1 radiosensitizes human breast cancer cells by inducing DNA damage and autophagy J Griffith, D Andrade, M Mehta, W Berry, DM Benbrook, N Aravindan, ... Oncology reports 37 (4), 2382-2390, 2017 | 19 | 2017 |
| Drug delivery approaches for HuR-targeted therapy for lung cancer R Raguraman, S Shanmugarama, M Mehta, JE Peterson, YD Zhao, ... Advanced drug delivery reviews 180, 114068, 2022 | 18 | 2022 |
| Influence of novel KGFR tyrosine kinase inhibitors on KGF-mediated proliferation of breast cancer M Mehta, JW Kesinger, XP Zang, ML Lerner, DJ Brackett, ... Anticancer research 30 (12), 4883-4889, 2010 | 17 | 2010 |
| IL-24 inhibits lung cancer growth by suppressing GLI1 and inducing DNA damage J Panneerselvam, A Srivastava, M Mehta, A Chen, YD Zhao, A Munshi, ... Cancers 11 (12), 1879, 2019 | 13 | 2019 |
| Designing of tumor-targeted HuR siRNA nanoparticle as a therapeutic for lung cancer R Muralidharan, A Babu, K Basalingappa, M Mehta, A Munshi, R Ramesh Multi-Targeted Approach to Treatment of Cancer, 277-294, 2015 | 6 | 2015 |
